No problem, I feel it is really needed at this point, because of the recent posts that cause more confusion on the actual diagnoses of IBS and the cause/causes.
People are posting IBS is an infections disease or food allergy, or toxins or bacterial infection, or fungus, or pathogens this is totally inaccurate. Those condition if some exist at all to begin with are not IBS, but there own seperate conditions.
Experts are working very hard to validate functional gi disorders as real seperate entities.
I will get to the candida in a bit here.
Next a history of the funtional Bowel disorders.
This is from the President of the Rome commitee to diagnosed functional disorders.
History of Functional Disorders
THE PAST
HISTORICAL PRECEDENTS
Historians and physicians have documented the presence of Functional GI disorders throughout
recorded human history. However, until recently, limited attention has been granted to these
disorders due to the lack of identifiable pathology and the absence of a conceptual framework to
understand and categorize them. Systematic investigation of functional GI disorders did not
begin until the middle of the 20th century, and prior to this time, only occasional reports of
functional GI symptoms were published, the first appearing only 200 years ago.
Over the past 25 years, scientific attention to understanding and properly caring for patients with
functional GI disorders has grown progressively. With the understanding comes the rationale for
use of medications directed at intestinal receptors as well as psychopharmacological, behavioral,
and psychological forms of treatment. Additionally, there has been an increase in the rate of
scientific publications and greater media exposure to the public through television, radio, and
Internet.
To understand the historical classification of these disorders, two differing theories relating to the
interaction between the mind and body should be considered."
More explain in the document.
'THE PRESENT
CONCEPTUAL BASES FOR THE STUDY OF FUNCTIONAL GI DISORDERS
o The recent acceptance of functional GI disorders as legitimate medical entities is
based on the following three developments:
o The concept of the Biopsychosocial model of illness and disease
o The development of new investigative methods for studying disease
o The development of the Rome Criteria
Biopsychosocial Model
In 1977, the publication of the concept of the Biopsychosocial model by George Engel, and its
later demonstration specifically for gastrointestinal disorders, marked an important change in
thinking. A biopsychosocial model of illness and disease provides the needed framework to understand, categorize, and treat common GI symptoms. These symptoms are the integrated
product of altered motility, enhanced visceral sensitivity, and brain-gut dysregulation and often
are influenced by psychosocial factors. Figure 1 illustrates the proposed relationship between
psychosocial and physiological factors with functional GI symptoms and the clinical outcome.
Early in life, genetics and environmental influences (family attitudes toward bowel training or
illness in general, major loss or abuse history or exposure to infection) may affect one's
psychosocial development (susceptibility to life stress, psychological state, coping skills, social
support) or the development of gut dysfunction (abnormal motility or visceral hypersensitivity).
Additionally, the presence and nature of a functional GI disorder is determined by the interaction
of psychosocial factors and altered physiology via the brain-gut axis. In other words, one
individual afflicted with a bowel disorder but with no psychosocial disturbances, good coping
skills and adequate social support may have less severe symptoms and not seek medical care.
Another having similar symptoms but with coexistent psychosocial disturbance, high life stress,
or poor coping skills may frequent his physician's office and have generally poor outcome.
DEVELOPMENT OF NEW INVESTIGATIVE METHODS
The second concurrent process has been the expansion and refinement of investigative methods
that allow the study of functional GI disorders in terms of biological, cultural, and psychosocial
(i.e. brain) influences. These developments include:
1. the improvement of motility assessment,
2. the standardization of the barostat to measure visceral sensitivity,
3. the enhancement of psychometric instruments to determine psychosocial
influences,
4. the introduction of brain imaging (PET, fMRI) to determine CNS contribution to
symptoms, and
5. the molecular investigation of brain-gut peptides, which provide insight into how
these symptoms become manifest.
In less than ten years, these methods have produced new knowledge of the underlying
pathophysiological features that characterize the age-old symptoms we now define as functional
GI disorders.
ROME CRITERIA
The Rome Criteria is an international effort to characterize and classify the functional GI
disorders using a symptom-based classification system. This approach that has its precedents
with classification systems in psychiatry and rheumatology. The rationale for such a system is
based on the premise that patients with functional GI complaints consistently report symptoms
that breed true in their clinical features, yet cannot be classified by any existing structural,
physiological or biochemical substrate. The Rome Criteria was built upon the Manning Criteria,
which was developed from discriminate function analysis of GI patients.
The decision to develop diagnostic criteria by international consensus was introduced as part of a
larger effort to address issues within gastroenterology that are not easily resolved by usual
The UNC Center for Functional GI http://www.med.unc.edu/ibs
& Motility Disorders
4
scientific inquiry or literary review. By 1992, several committees had met to discuss the criteria,
which ultimately resulted in the publishing of many articles in Gastroenterology International
and a book detailing the criteria titled "The Functional Gastrointestinal Disorders (Rome I)".
Elaboration of the Rome I criteria led to a second edition of the Rome criteria (titled Rome II) in
2000 as well as the publication of a supplement to the journal Gut in 1999. Recently the Rome
Coordinating Committee has met to begin Rome III, expected to be published in 2006. To learn
more about the Rome Committees and to see a summary of the Rome II book: go to
www.romecriteria.com.
PRESENT PATHOPHYSIOLOGICAL OBSERVATIONS
Despite differences among the functional gastrointestinal disorders, in location and symptom
features, common characteristics are shared with regard to:
o motor and sensory physiology,
o central nervous system relationships,
o approach to patient care.
What follows are the general observations and guidelines.
MOTILITY
In healthy subjects, stress can increase motility in the esophagus, stomach, small and large
intestine and colon. Abnormal motility can generate a variety of GI symptoms including
vomiting, diarrhea, constipation, acute abdominal pain, and fecal incontinence. Functional GI
patients have even greater increased motility in response to stressors in comparison to normal
subjects. While abnormal motility plays a vital role in understanding many of the functional GI
disorders and their symptoms, it is not sufficient to explain reports of chronic or recurrent
abdominal pain.
VISCERAL HYPERSENSITIVITY
Visceral hypersensitivity helps to account for disorders associated with chronic or recurrent pain,
which are not well correlated with changes in gastrointestinal motility, and in some cases, where
motility disturbances do not exist. Patients suffering from visceral hypersensitivity have a lower
pain threshold with balloon distension of the bowel or have increased sensitivity to even normal
intestinal function. Additionally, there may be an increased or unusual area of somatic referral of
visceral pain. Recently it has been concluded that visceral hypersensitivity may be induced in
response to rectal or colonic distension in normal subjects, and to a greater degree, in persons
with IBS. Therefore, it is possible that the pain of functional GI disorders may relate to
sensitization resulting from chronic abnormal motor hyperactivity, GI infection, or trauma/injury
to the viscera.
BRAIN-GUT AXIS
The concept of brain-gut interactions brings together observations relating to motility and
visceral hypersensitivity and their modulation by psychosocial factors. By integrating intestinal
and CNS central nervous system activity, the brain-gut axis explains the symptoms relating to
functional GI disorders. In other words, senses such as vision and smell, as well as enteroceptive
information (i.e. emotion and thought) have the capability to affect gastrointestinal sensation,
motility, secretion, and inflammation. Conversely, viscerotopic effects reciprocally affect central
pain perception, mood, and behavior. For example, spontaneously induced contractions of the
colon in rats leads to activation of the locus coeruleus in the pons, an area closely connected to
pain and emotional centers in the brain. Jointly, the increased arousal or anxiety is associated
with a decrease in the frequency of MMC activity of the small bowel possibly mediated by stress
hormones in the brain. Based on these observations, it is no longer rational to try to discriminate
whether physiological or psychological factors produce pain or other bowel symptoms. Instead,
the Functional GI disorders are understood in terms of dysregulation of brain-gut function, and
the task is to determine to what degree each is remediable. Therefore, a treatment approach
consistent with the concept of brain-gut dysfunction may focus on the neuropeptides and
receptors that are present in both enteric and central nervous systems.
THE ROLE FOR PSYCHOLOGICAL FACTORS
Although psychological factors do not define these disorders and are not required for diagnosis,
they are important modulators of the patient's experience and ultimately, the clinical outcome.
Research on the psychosocial aspects of patients with functional GI disorders yields three general
observations:
o Psychological stress exacerbates gastrointestinal symptoms in patients with
functional GI disorders and can even produce symptoms in healthy patients (but to
a lesser degree).
o Psychological disturbances modify the experience of illness and illness behaviors
such as health care seeking. For example, a history of major psychological trauma
(e.g. sexual or physical abuse) is more common among patients seen in referral
centers than in primary care and is associated with a more severe disorder and a
poorer clinical outcome. Additionally, psychological trauma may increase painreporting
tendency.
o Having a functional GI disorder has psychological consequences in terms of one's
general well-being, daily functional status, concerns relating to control over
symptoms, and future implications of the illness (e.g. functioning at work and
home).
APPROACH TO TREATMENT
The approach to treatment for all functional GI disorders is founded on a therapeutic physicianpatient
relationship. The basis for implementing a strong physician-patient relationship is
supported by evidence that patients with functional GI disorders have anywhere from a 30 to
80% placebo response rate regardless of treatment.
http://www.med.unc.edu/medicine/fgidc/historyfunctionaldisorders.pdf
This is important to notice and understand also
" functional GI disorders have anywhere from a 30 to
80% placebo response rate regardless of treatment."
This is an excellent new video.
An interview with Douglas A. Drossman, MD, Co-Director, UNC Center for Functional GI & Motility Disorders, University of North Carolina, Chapel Hill, NC. Dr. Drossman is a clinician, a clinical researcher, and an educator. In this video, Dr. Drossman explains continuing advances that help us understand and visualize these conditions.
http://www.youtube.com/watch?v=bm3gboLimvw
--------------------
My website on IBS is www.ibshealth.com
Print
Remind Me
Notify Moderator
|
Posts
Re: Thanks for the info Shawneric -nt-
